SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · IEX Real-Time Price · USD
15.27
-0.29 (-1.86%)
At close: Apr 23, 2024, 4:00 PM
15.87
+0.60 (3.93%)
Pre-market: Apr 24, 2024, 7:52 AM EDT
SI-BONE Market Cap
SI-BONE has a market cap or net worth of $627.05 million as of April 24, 2024. Its market cap has decreased by -9.80% in one year.
Market Cap
627.05M
Enterprise Value
500.03M
1-Year Change
-9.80%
Ranking
Category
Stock Price
$15.27
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $437.20M to $627.05M, an increase of 43.43%. That is a compound annual growth rate of 6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2024 | 639.00M | 0.92% |
| Apr 19, 2024 | 633.20M | 0.78% |
| Apr 18, 2024 | 628.30M | 0.46% |
| Apr 17, 2024 | 625.40M | -0.71% |
| Apr 16, 2024 | 629.90M | 0.45% |
| Apr 15, 2024 | 627.10M | 2.02% |
| Apr 12, 2024 | 614.70M | -4.59% |
| Apr 11, 2024 | 644.30M | -1.81% |
| Apr 10, 2024 | 656.20M | -2.21% |
| Apr 9, 2024 | 671.00M | 6.66% |
| Apr 8, 2024 | 629.10M | -0.27% |
| Apr 5, 2024 | 630.80M | -0.25% |
| Apr 4, 2024 | 632.40M | -2.84% |
| Apr 3, 2024 | 650.90M | 1.80% |
| Apr 2, 2024 | 639.40M | -1.33% |
| Apr 1, 2024 | 648.00M | -3.60% |
| Mar 28, 2024 | 672.20M | 3.48% |
| Mar 27, 2024 | 649.60M | 3.39% |
| Mar 26, 2024 | 628.30M | 1.00% |
| Mar 25, 2024 | 622.10M | -0.65% |
| Mar 22, 2024 | 626.20M | -2.87% |
| Mar 21, 2024 | 644.70M | -2.07% |
| Mar 20, 2024 | 658.30M | -0.74% |
| Mar 19, 2024 | 663.20M | 1.25% |
| Mar 18, 2024 | 655.00M | -0.56% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quanterix | 646.38M |
| HilleVax | 645.61M |
| Aerovate Therapeutics | 640.57M |
| Mind Medicine (MindMed) | 638.73M |
| The Pennant Group | 636.57M |
| Cross Country Healthcare | 628.01M |
| GH Research | 626.94M |
| Lyell Immunopharma | 623.81M |